MRC Holland at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

MRC Holland brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 643. Its program centres on copy number and methylation testing with MLPA probemixes, alongside nucleic acid extraction for liquid biopsy and FFPE oncology workflows. Presented work covers a multicentre validation of methylation-sensitive digitalMLPA for homologous recombination repair assessment.

OrganizationAMP 2026 Attendance
MRC Holland
Amsterdam, Netherlands
Diagnostics
Assays for gene copy number and methylation detection, including MLPA and digitalMLPA probemixes for hereditary disorders and tumour profiling.
Booth
Exhibiting at Booth 643
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
1:00pm–1:50pm
Strategies for Optimizing Nucleic Acid Extraction in Molecular Oncology Workflows: Liquid Biopsy, FFPE, and Beyond
Magnetic bead extraction tuned for high-throughput oncology workflows, covering FFPE tissue and cell-free DNA from plasma.
Workshop hosted by Revvity

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from MRC Holland

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction